BioCentury
ARTICLE | Financial News

Valeant announces $1.5B share repurchase program

November 20, 2012 1:42 AM UTC

Valeant Pharmaceuticals International Inc. (TSX:VRX; NYSE:VRX) said its board authorized the repurchase of up to $1.5 billion of the company's securities through Nov. 14, 2013. At Sept. 30, Valeant had $257.7 million in cash and a nine-month operating income of $177.8 million. As of Nov. 19, the company had about 303.4 million shares outstanding. ...